Stocktoria
Oncology Institute, Inc. TOI
Nasdaq · XNAS · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2020-03-13
Oncology Institute, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $502.7M | $393.4M | $324.2M | $252.5M | $203.0M |
| SG&A expense | $105.6M | $107.8M | $113.9M | $119.7M | $83.4M |
| Operating income | -$36.1M | -$60.1M | -$77.0M | -$82.0M | -$45.9M |
| Interest expense | — | — | — | — | $320,000 |
| Income tax | -$131,000 | $0 | -$36,000 | -$243,000 | -$671,000 |
| Net income | -$60.6M | -$64.7M | -$83.1M | $152,000 | -$10.9M |
| EPS (diluted) | $-0.54 | $-0.71 | $-0.92 | $-0.21 | $-0.16 |
| Operating cash flow | -$24.6M | -$26.5M | -$36.3M | -$61.8M | -$32.7M |
| Free cash flow | -$27.8M | -$30.3M | -$40.9M | -$67.3M | -$35.5M |
| Inventory | $16.9M | $10.0M | $13.7M | $9.3M | $6.4M |
| Total assets | $164.7M | $172.7M | $209.2M | $261.7M | $203.4M |
| Total liabilities | $180.4M | $169.1M | $152.2M | $138.5M | $99.3M |
| Shareholders' equity | -$15.7M | $3.6M | $57.0M | $123.2M | $104.2M |
Source: SEC EDGAR filings · CIK 0001799191 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.